Suven Life Sciences Income Statement

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021
Operating Revenue	70.62	66.56	116.93	135.39	118.44	134.78
Other Revenue	-	-	-	0.56	1.06	5.95
Revenue	70.62	66.56	116.93	135.95	119.51	140.73
Revenue Growth (YoY)	-6.77%	-43.08%	-13.99%	13.76%	-15.08%	-4.30%
Cost of Revenue	7.51	7.51	8.24	5.66	24.33	1.03
Gross Profit	63.1	59.05	108.69	130.29	95.18	139.7
Selling, General & Admin	246.79	211.17	190.24	186.21	210.21	185.36
Research & Development	2,432	1,440	1,144	1,154	1,064	710.27
Other Operating Expenses	157.37	61.96	52.08	45.56	39.53	33.45
Operating Expenses	2,890	1,771	1,452	1,451	1,357	972.55
Operating Income	-2,827	-1,712	-1,343	-1,320	-1,262	-832.85
Interest Expense	-	-0.47	-1.58	-2.89	-5.32	-8.15
Interest & Investment Income	56.83	56.83	164.25	64.16	11.26	69.79
Currency Exchange Gain (Loss)	-2.27	-2.27	-0.7	-3.28	-3.71	-4.14
Other Non Operating Income (Expenses)	-24.6	0.62	0	-	0	-
EBT Excluding Unusual Items	-2,797	-1,657	-1,181	-1,262	-1,260	-775.35
Gain (Loss) on Sale of Investments	49.76	49.76	45.49	17.92	3.56	0.61
Asset Writedown	-	-	-	-0.02	-0.86	-
Other Unusual Items	-	-	0.11	1.85	0.13	-
Pretax Income	-2,747	-1,607	-1,061	-1,183	-1,220	-774.74
Income Tax Expense	-	-	-10.02	-	-	-53.23
Net Income	-2,747	-1,607	-1,051	-1,183	-1,220	-721.51
Net Income to Common	-2,747	-1,607	-1,051	-1,183	-1,220	-721.51
Shares Outstanding (Basic)	222	218	218	178	135	127
Shares Outstanding (Diluted)	222	218	218	178	135	127
Shares Change (YoY)	2.11%	-	22.31%	32.29%	5.88%	-
EPS (Basic)	-12.35	-7.37	-4.82	-6.63	-9.05	-5.67
EPS (Diluted)	-12.35	-7.37	-4.82	-6.63	-9.05	-5.67
Free Cash Flow	-	-1,914	-1,155	-1,189	-1,473	-1,023
Free Cash Flow Per Share	-	-8.78	-5.29	-6.67	-10.93	-8.04
Dividend Per Share	-	-	-	-	1.000	-
Gross Margin	89.36%	88.71%	92.95%	95.84%	79.64%	99.27%
Operating Margin	-4002.84%	-2572.07%	-1148.48%	-971.27%	-1056.14%	-591.80%
Profit Margin	-3889.96%	-2415.11%	-898.63%	-869.95%	-1020.82%	-512.69%
Free Cash Flow Margin	-	-2875.39%	-987.51%	-874.42%	-1232.64%	-727.12%
EBITDA	-2,778	-1,659	-1,285	-1,262	-1,227	-797.75
D&A For EBITDA	48.94	52.78	57.89	58	35.41	35.09
EBIT	-2,827	-1,712	-1,343	-1,320	-1,262	-832.85
Revenue as Reported	154.36	175.53	328.23	219.88	134.46	212.32

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.